Drug addiction is a chronic, relapsing disorder, which is caused by many factors including genetic, epigenetic, environmental, and drug-related (Robison and Nestler, 2011). Loss of control over drug intake and compulsion for drug taking are the most characteristic features of addiction (Koob and Volkow, 2010). Although many individuals are exposed to substances of abuse, only subsets enter the addicted state. However, if the addicted state develops, it persists for life, suggesting that the underlying molecular changes in the brain are long-lasting. The present research topic was selected to highlight several new insights about genetic and drug-related factors that contribute to drug-induced neuroplastic changes.Because dopaminergic cells play a pivotal role in the rewarding action of drugs of abuse, they were the starting point for the study of drug-induced synaptic alterations. Rodriguez Parkitna and Engblom (2012) added new insights to our knowledge about the synaptic plasticity of dopaminergic cells in the ventral tegmental area focusing on NMDA and AMPA receptor functions. For this, knockout mice with selective deletion of the NR1 subunit of the NMDA receptors were used. They examined NMDA receptor plasticity and burst firing activity, and found that this plays an important role in reward learning. Furthermore, they show NMDA receptors on dopaminergic cells are involved in drug-induced associative learning and in recall of drug-associated experiences.Withdrawal is an unbalanced state characterized by increased stress, anxiety, and depression. During chronic drug consumption and withdrawal, the brain stress response system becomes dysregulated. The expression of several neuropeptides, including corticotropin releasing factor (CRF), neuropeptide Y, and dynorphin are stress-related. Furthermore, these neuropeptides are involved in the modulation of negative emotional states associated with drug addiction (Boutrel and De Lecea, 2008;Allen et al., 2011;Bruijnzeel, 2012).Yadid et al. in their focused review (Yadid et al., 2012) concentrated on the neuroadaptive processes occurring during withdrawal. Evidence shows that endogenous opioid peptides β-endorphin, enkephalin, and dynorphin play an important role in substance reinforcement. β-endorphin and the neurosteroid dehydroepiandrosterone (DHEA) both modulate mood and drug addiction, and these modulatory functions are linked with each other. Application of exogenous DHEA-S (phosphorylated DHEA) into the nucleus accumbens elevated the level of extracellular β-endorphin. Thus, modulation of DHEA level in the brain may regulate extracellular β-endorphin levels which consequently controls stress coping including mood fluctuations.Together, these processes end up regulating the craving for drugs of abuse.Dempsey and Grisel (2012) in their research paper examined the role of β-endorphin in the development of locomotor sensitization to repeated chronic alcohol exposure. They found that mice lacking β-endorphin did not develop locomotor sensitization to alcohol. These fi...